Anderson G, Hardy D, Hillesheim P, Wagle D, Zeller M, Baker G
ACS Phys Chem Au. 2023; 3(1):94-106.
PMID: 36718259
PMC: 9881241.
DOI: 10.1021/acsphyschemau.2c00048.
Vu D, Pham M, Nguyen V, Le T
Ther Clin Risk Manag. 2022; 18:11-19.
PMID: 35023921
PMC: 8747785.
DOI: 10.2147/TCRM.S344464.
Rahman M, Alam M, Alfaifi S, Asiri A, Ali M
Polymers (Basel). 2021; 13(22).
PMID: 34833297
PMC: 8618075.
DOI: 10.3390/polym13223998.
Croce L, Di Dalmazi G, Orsolini F, Virili C, Brigante G, Gianetti E
Front Endocrinol (Lausanne). 2020; 10:853.
PMID: 31920967
PMC: 6914725.
DOI: 10.3389/fendo.2019.00853.
Yoo D, Jung H, Kwon H, Kim J, Nam S, Chung J
Food Sci Biotechnol. 2018; 25(6):1761-1766.
PMID: 30263472
PMC: 6049245.
DOI: 10.1007/s10068-016-0268-3.
Hypothyroidism increases cyclooxygenase-2 levels and pro-inflammatory response and decreases cell proliferation and neuroblast differentiation in the hippocampus.
Nam S, Kim J, Yoo D, Jung H, Chung J, Kim D
Mol Med Rep. 2018; 17(4):5782-5788.
PMID: 29436670
PMC: 5866021.
DOI: 10.3892/mmr.2018.8605.
Skin whitening agents: medicinal chemistry perspective of tyrosinase inhibitors.
Pillaiyar T, Manickam M, Namasivayam V
J Enzyme Inhib Med Chem. 2017; 32(1):403-425.
PMID: 28097901
PMC: 6010116.
DOI: 10.1080/14756366.2016.1256882.
Radioiodine therapy versus antithyroid medications for Graves' disease.
Ma C, Xie J, Wang H, Li J, Chen S
Cochrane Database Syst Rev. 2016; 2:CD010094.
PMID: 26891370
PMC: 10517434.
DOI: 10.1002/14651858.CD010094.pub2.
Mitigation of Methimazole-Induced Hepatic Injury by Taurine in Mice.
Heidari R, Jamshidzadeh A, Keshavarz N, Azarpira N
Sci Pharm. 2016; 83(1):143-58.
PMID: 26839807
PMC: 4727863.
DOI: 10.3797/scipharm.1408-04.
Repositioning of Thiourea-Containing Drugs as Tyrosinase Inhibitors.
Choi J, Jee J
Int J Mol Sci. 2015; 16(12):28534-48.
PMID: 26633377
PMC: 4691061.
DOI: 10.3390/ijms161226114.
Chylous Ascites: A Rare Adverse Effect of Methimazole Treatment for Grave's Disease-A Case Report and Review of the Literature.
Khoury T, Schneider R
Case Rep Endocrinol. 2015; 2015:649303.
PMID: 26366308
PMC: 4561093.
DOI: 10.1155/2015/649303.
Development of Agranulocytosis after Discontinuation of Methimazole: An Unusual Case.
Ucler R, Atmaca M, Candar O, Alay M, Goy B, Kara E
Case Rep Endocrinol. 2015; 2015:974524.
PMID: 26339512
PMC: 4538967.
DOI: 10.1155/2015/974524.
Antineutrophilic Cytoplasmic Antibody Positive Vasculitis Associated with Methimazole Use.
Shikha D, Harris J, Resta C, Park P
Case Rep Endocrinol. 2015; 2015:530319.
PMID: 26060588
PMC: 4427812.
DOI: 10.1155/2015/530319.
An overview on the proposed mechanisms of antithyroid drugs-induced liver injury.
Heidari R, Niknahad H, Jamshidzadeh A, Eghbal M, Abdoli N
Adv Pharm Bull. 2015; 5(1):1-11.
PMID: 25789213
PMC: 4352210.
DOI: 10.5681/apb.2015.001.
Simple modifications to methimazole that enhance its inhibitory effect on tumor necrosis factor-α-induced vascular cell adhesion molecule-1 expression by human endothelial cells.
Alapati A, Deosarkar S, Lanier O, Qi C, Carlson G, Burdick M
Eur J Pharmacol. 2015; 751:59-66.
PMID: 25641748
PMC: 5019189.
DOI: 10.1016/j.ejphar.2015.01.032.
Iodide protects heart tissue from reperfusion injury.
Iwata A, Morrison M, Roth M
PLoS One. 2014; 9(11):e112458.
PMID: 25379708
PMC: 4224479.
DOI: 10.1371/journal.pone.0112458.
Hypothyroidism affects astrocyte and microglial morphology in type 2 diabetes.
Nam S, Kim Y, Yoo D, Yi S, Choi J, Hwang I
Neural Regen Res. 2014; 8(26):2458-67.
PMID: 25206556
PMC: 4146114.
DOI: 10.3969/j.issn.1673-5374.2013.26.007.
Does propylthiouracil increase the gentamicin-induced nephrotoxicity in rat?.
Sepehri G, Derakhshanfar A, Saburi L
Iran J Basic Med Sci. 2014; 16(11):1190-5.
PMID: 24494072
PMC: 3909631.
Sepsis mimicking thyroid storm in a patient with methimazole-induced agranulocytosis.
Rayner S, Hosseini F, Adedipe A
BMJ Case Rep. 2013; 2013.
PMID: 23861276
PMC: 3736612.
DOI: 10.1136/bcr-2013-200145.
Biosynthesis of 3-iodothyronamine (T1AM) is dependent on the sodium-iodide symporter and thyroperoxidase but does not involve extrathyroidal metabolism of T4.
Hackenmueller S, Marchini M, Saba A, Zucchi R, Scanlan T
Endocrinology. 2012; 153(11):5659-67.
PMID: 22948220
PMC: 3473208.
DOI: 10.1210/en.2012-1254.